Evaluation of the efficacy of Thalidomide as Maintenance Therapy after Autologous Peripheral Blood Stem Cell Transplantation for Patients with Multiple Myeloma

Hisham Mahmoud Eissa;

Abstract


Purpose: The aim of the present study was to compare the outcome of the
multiple myeloma (MM) patients who underwent autologous stem cell transplant
(ASCT) and received post-ASCT maintenance thalidomide, to those who didn’t.
Patients and Methods: Thirt


Other data

Title Evaluation of the efficacy of Thalidomide as Maintenance Therapy after Autologous Peripheral Blood Stem Cell Transplantation for Patients with Multiple Myeloma
Authors Hisham Mahmoud Eissa
Keywords Evaluation of the efficacy of Thalidomide as Maintenance Therapy after Autologous Peripheral Blood Stem Cell Transplantation for Patients with Multiple Myeloma
Issue Date 2009
Description 
Purpose: The aim of the present study was to compare the outcome of the
multiple myeloma (MM) patients who underwent autologous stem cell transplant
(ASCT) and received post-ASCT maintenance thalidomide, to those who didn’t.
Patients and Methods: Thirt

Attached Files

File SizeFormat
74437r904.pdf148.68 kBAdobe PDFView/Open
Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check

views 2 in Shams Scholar


Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.